HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.
White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.
Henry Brem Named Director Of Neurology At Johns Hopkins.
Cancer Groups Oppose Plan To Cut Drug Reimbursement.
Edward Benz Named President Of Dana-Farber Cancer Institute.
Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.
75% Of Fed Research Funds Pay Direct Costs, Study Says.
More Women Over 50 Report Having Had Mammograms.
US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.
FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.
Sweden Approves Photofrin For Palliation Of Two Cancers.
Firm Buys Rights To NKT Cells From Beth Israel Deaconess.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
